Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Nathan

Showing results (141-150 of 297) with videos related to

Pageof 30
Sort By:
Transplantation Direct|December 19, 2025
Plasma Cell-free DNA Associated With Risk of Mortality and Chronic Lung Allograft Dysfunction Among Lung Transplant Recipients With <i>Aspergillus</i>Yasir Hamad, Joby Mathew, Temesgen Andargie, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 18, 2023
Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORDSteven D Nathan, Abhimanyu Chandel, Ya Wang, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2025
Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung TransplantSteven D Nathan, Ho Cheol Kim, Christopher S King, et al.
Pulmonary Circulation|January 11, 2024
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary HypertensionOksana A Shlobin, Eric Shen, Stephen J Wort, et al.
American Journal of Respiratory and Critical Care Medicine|November 12, 2021
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE TrialSteven D Nathan, Victor F Tapson, Jean Elwing, et al.
Chest|July 7, 2011
Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millenniumSteven D Nathan, Oksana A Shlobin, Nargues Weir, et al.
Pulmonary Circulation|June 21, 2024
Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysisTracey Weiss, Dena R Ramey, Ngan Pham, et al.
Respiratory Medicine|March 13, 2013
Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertensionAli A Weinstein, Lisa M K Chin, Randall E Keyser, et al.
Chest|May 19, 2026
Evolving Concepts in Pulmonary Hypertension: Implementation challenges of the current guidelines and proceedings in the USSandeep Sahay, Rodolfo A Estrada, Megan Griffiths, et al.
JHLT Open|March 27, 2025
Discrepancy between pulmonary arterial wedge pressure and left ventricular end diastolic pressure in patients with interstitial lung diseaseHo Cheol Kim, Onix Cantres Fonseca, Behnam N Tehrani, et al.
Pageof 30

Showing results (141-150 of 297) with videos related to

Sort By:
Pageof 30
Transplantation Direct|December 19, 2025
Plasma Cell-free DNA Associated With Risk of Mortality and Chronic Lung Allograft Dysfunction Among Lung Transplant Recipients With <i>Aspergillus</i>Yasir Hamad, Joby Mathew, Temesgen Andargie, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 18, 2023
Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORDSteven D Nathan, Abhimanyu Chandel, Ya Wang, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2025
Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung TransplantSteven D Nathan, Ho Cheol Kim, Christopher S King, et al.
Pulmonary Circulation|January 11, 2024
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary HypertensionOksana A Shlobin, Eric Shen, Stephen J Wort, et al.
American Journal of Respiratory and Critical Care Medicine|November 12, 2021
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE TrialSteven D Nathan, Victor F Tapson, Jean Elwing, et al.
Chest|July 7, 2011
Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millenniumSteven D Nathan, Oksana A Shlobin, Nargues Weir, et al.
Pulmonary Circulation|June 21, 2024
Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysisTracey Weiss, Dena R Ramey, Ngan Pham, et al.
Respiratory Medicine|March 13, 2013
Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertensionAli A Weinstein, Lisa M K Chin, Randall E Keyser, et al.
Chest|May 19, 2026
Evolving Concepts in Pulmonary Hypertension: Implementation challenges of the current guidelines and proceedings in the USSandeep Sahay, Rodolfo A Estrada, Megan Griffiths, et al.
JHLT Open|March 27, 2025
Discrepancy between pulmonary arterial wedge pressure and left ventricular end diastolic pressure in patients with interstitial lung diseaseHo Cheol Kim, Onix Cantres Fonseca, Behnam N Tehrani, et al.
Pageof 30